Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Tharos who wrote (8108)	12/22/1998 10:18:00 AM
From: aknahow	Read Replies (1) \| Respond to of 17367

I believe one of the big products is shark cartilage for cancer. $250 million is not a lot and as to the fish maturing faster, I would need to see the original study, not just a review, unless of course it was supposedly BPI that made them grow faster. <g> I wish to remind you that the capitalistic system of the U.S. has enabled our fishermen to catch fish that are twice as big as before they were caught, keeping us ahead of anything one of the last bastions of Communism can do with genetics.

To: Tharos who wrote (8108)	12/23/1998 12:55:00 AM
From: aknahow	Read Replies (1) \| Respond to of 17367

Sometimes Pavlov rings the bell late. Not a novel patent, but better than no patent. <g> 1 of 39) United States Patent 5,851,802 Better Dec. 22, 1998 Methods for recombinant microbial production of fusion proteins and BPI-derived peptides Abstract The present invention relates to methods and materials for the recombinant microbial production of fusion proteins and peptides derived from or based on Domain I (amino acids 17-45), Domain II (amino acids 65-99) and Domain III (amino acids 142-169) of bactericidal/permeability-increasing protein (BPI).

To: Tharos who wrote (8108)	12/23/1998 2:18:00 AM
From: jackie	Read Replies (1) \| Respond to of 17367

Tharos, I cannot resist the irony. In this country, which claims to believe in freedom to choose, freedom to make financial choices, freedom of medical care, one cannot obtain Neuprex for a child sick with a gram negative bacterium because 'the state has determined one can't be too careful in these situations (via FDA regulations).' It really is better, believe it or not, to permit the child to die while we work out some sort of agreement on the safety and efficacy of a drug in a long, drawn out bureaucratic process. Yet, in a country where one cannot grow and sell vegetables for a profit, there is a vigorous biotech industry. AND THE RESULTS ARE FREELY AVAILABLE WORLDWIDE!!!!!! How does one account for this free application of biotechnology in Cuba? I seem to recall Fidel's brother was a physician. Is that true? Does this explain this apparent loophole in Cuban policy? No matter. They love biotech in Cuba. Well, since the management of XOMA is so enamored of a Caribbean domicile and Castro is so enamored of biotech as to set aside his socialistic ideals for its benefit, move XOMA headquarters to Cuba! Maybe then, BPI would be freely sold worldwide, with one exception. Of course, Neuprex would be an illegal drug (in the United States), but as the Caribbean is very good at moving illegal drugs into the United States, everyone would benefit. Who knows, we could be treated to scenes of COPS where the announcer tells us they about to launch a raid against a suspected BPI house. The potential here is unlimited. Then again, maybe management would not be so keen on chopping sugar cane every year during the harvest. Sorry folks for this outburst of cynicism. But sometimes I just cannot stand the stupidity of our institutions. Regards, Jack